Bio-Pen Injection
PDF Leaflet Revision Date: 04 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by benzylpenicillin sensitive microorganisms.
Dosage (summary)
Adults: 500,000 u2013 20 million units daily; Severe infections: 20 million units daily.
Special Populations
- Renal impairment
- Hepatic impairment
- History of allergy
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; excreted in breast milk.
Key Drug Interactions
- Probenecid
- Oral contraceptives
- Methotrexate
- Digoxin
Contraindications
- Hypersensitivity to benzylpenicillin
- Allergy to penicillin or cephalosporins
Common side effects
- Diarrhea
- Nausea
- Allergic reactions
- Electrolyte imbalances
Counselling Points
- Monitor for hypersensitivity reactions
- Inform about potential interactions with oral contraceptives
- Advise on signs of superinfection
Serious warnings
- Anaphylactic shock
- Severe cutaneous adverse reactions
- Caution in patients with history of allergy
Important Disclaimer
The Bio-Pen Injection professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
